Skip to main content

Animations

MJFF Publications

4151 - 4160 of 8808 Results
Title
Year
  • Year
  • 2019
  • 2020
  • 2019
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: A cornerstone initiative for progress in Parkinson's disease
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30432-6
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Annual Prevalence of Use of Potentially Inappropriate Medications for Treatment of Affective Disorders in Parkinson's Disease
    Journal Name: The American Journal of Geriatric Psychiatry
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jagp.2020.05.014
    Citation Count: 5
  • Summary Details
    RESTRICTED
    Title: Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study
    Journal Name: The Lancet Neurology
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/s1474-4422(19)30396-5
    Citation Count: 112
  • Summary Details
    RESTRICTED
    Title: Neural activity in functional movement disorders after inpatient rehabilitation
    Journal Name: Psychiatry Research: Neuroimaging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.pscychresns.2020.111125
    Citation Count: 27
  • Summary Details
    RESTRICTED
    Title: Does increased forefoot load contribute to freezing of gait in Parkinson's disease? A clinical observation
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.021
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Getting ahead in the race for a cure: How nonprofits are financing biomedical R&D
    Journal Name: Research Policy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.respol.2020.104032
    Citation Count: 4
  • Summary Details
    OPEN
    Title: Analysis of heterozygous PRKN variants and copy number variations in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.123
    Citation Count: 6
  • Summary Details
    RESTRICTED
    Title: Impact of Levodopa/Carbidopa Intestinal Gel Delivery on CarePartner Burden and Quality of Life: Survey by Parkinson & Movement disorder alliance
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.325
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: Impact of OFF periods on aspects of employment for people with Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.323
    Citation Count: 1
  • Summary Details
    RESTRICTED
    Title: Detecting bradykinesia in early morning “OFF” episodes: a large database study using the Personal KinetiGraph® (PKG®)
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.06.322
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.